The impact of changing pathogens of serious infections in hospitalized patients

被引:14
作者
McGowan, JE
机构
[1] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Med Infect Dis, Atlanta, GA USA
关键词
D O I
10.1086/314077
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
New epidemiological patterns are being observed for multidrug-resistant nosocomial organisms. Current problems include the appearance of resistance determinants in organisms that are virulent enough to cause infection in patients with normal host defenses. In addition, multidrug-resistant organisms are spreading from health care to community settings, and organisms from the community are spreading to health care settings. The appearance and spread of resistance can be examined both at a molecular level and on a larger scale involving several pathways. Potential pathways within institutions include the following: introduction of new strains from outside sources (e.g,, patients or health care workers from other institutions); exchange of resistance determinants via genetic mutation or transfer of genetic material; emergence or selection of resistant strains following exposure to antimicrobials; and clonal dissemination. Strategies such as multidisciplinary management of infections, appropriate infection control measures, and surveillance of resistance patterns are necessary to address the problem of resistance.
引用
收藏
页码:S124 / S130
页数:7
相关论文
共 75 条
[61]   Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995 [J].
Shortridge, VD ;
Doern, GB ;
Brueggemann, AB ;
Beyer, JM ;
Flamm, RK .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (05) :1186-1188
[62]   Emergence of vancomycin resistance in Staphylococcus aureus [J].
Smith, TL ;
Pearson, ML ;
Wilcox, KR ;
Cruz, C ;
Lancaster, MV ;
Robinson-Dunn, B ;
Tenover, FC ;
Zervos, MJ ;
Band, JD ;
White, E ;
Jarvis, WR .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (07) :493-501
[63]  
STREULENS M, 1998, BRIT MED J, V317, P652
[64]   vanA and vanB incorporate into an endemic ampicillin-resistant vancomycin-sensitive Enterococcus faecium strain:: Effect on interpretation of clonality [J].
Suppola, JP ;
Kolho, E ;
Salmenlinna, S ;
Tarkka, E ;
Vuopio-Varkila, J ;
Vaara, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (12) :3934-3939
[65]   Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides [J].
Tenover, FC ;
Lancaster, MV ;
Hill, BC ;
Steward, CD ;
Stocker, SA ;
Hancock, GA ;
O'Hara, CM ;
Clark, NC ;
Hiramatsu, K .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (04) :1020-1027
[66]  
TENOVER FC, 1998, PATHOLOGY EMERGING I, V2, P343
[67]   Rapid emergence of resistant coagulase-negative staphylococci on the skin after antibiotic prophylaxis [J].
Terpstra, S ;
Noordhoek, GT ;
Voesten, HGJ ;
Hendriks, B ;
Degener, JE .
JOURNAL OF HOSPITAL INFECTION, 1999, 43 (03) :195-202
[68]   Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998 [J].
Thornsberry, C ;
Jones, ME ;
Hickey, ML ;
Mauriz, Y ;
Kahn, J ;
Sahm, DF .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (06) :749-759
[69]   Regional dissemination of vancomycin-resistant enterococci resulting from interfacility transfer of colonized patients [J].
Trick, WE ;
Kuehnert, MJ ;
Quirk, SB ;
Arduino, MJ ;
Aguero, SM ;
Carson, LA ;
Hill, BC ;
Banerjee, SN ;
Jarvis, WR .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (02) :391-396
[70]   What can be done about resistance to antibiotics? [J].
Turnidge, J .
BMJ-BRITISH MEDICAL JOURNAL, 1998, 317 (7159) :645-647